Loading data for TCRT — first visit, this takes a few seconds.
Alaunos Therapeutics Inc. (TCRT)
NasdaqCM: TCRT
· Real-Time Price · USD
1.88
+0.00 (0.00%)
At close: Aug 21, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Alaunos Therapeutics Inc. (TCRT) Stock Price, Analysis & Data
0.00% (1D)
No data available
| Bid | 1.58 |
| Market Cap | 4.47M |
| Revenue (ttm) | 3K |
| Net Income (ttm) | -4.21M |
| -0.96 | |
| -1.75 | |
| n/a | |
| -2.93 | |
| P/B (ttm) | 3.25 |
| P/S (ttm) | 1490.41 |
| Earnings Date | Aug 14, 2025 |
| Ask | 2.19 |
| Volume | 3,329 |
| Avg. Volume (20D) | 15,048 |
| Open | 1.94 |
| Previous Close | 1.88 |
| Day's Range | 1.88 - 1.94 |
| 52-Week Range | 1.67 - 4.59 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About TCRT
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based i...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 24, 2005
Employees 1
Stock Exchange NasdaqCM
Ticker Symbol TCRT
Website https://www.alaunos.com
Financial Performance
In 2025, Alaunos Therapeutics's revenue was 5K, a decrease of -50% compared to the previous year's 10K. Earnings were -4.18M, a decrease of -10.75%.
Financial StatementsEarnings Surprise
Alaunos Therapeutics has released their quarterly earnings on Apr 1, 2024:
- Revenue of $0 misses estimates by $0, with -100.00% YoY decline.
- EPS of -17.09 misses estimates by -12.59, with -184.83% YoY decline.
Alaunos Therapeutics Inc. is scheduled to release its earnings on Aug 14, 2025, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
